Federal Circuit Upholds Ruling Invalidating University of Rochester's Patent

Law360, New York (February 14, 2004, 12:00 AM EST) -- The U.S. Court of Appeals for the Federal Circuit has upheld a lower court’s dismissal of the University of Rochester’s lawsuit against Pfizer over the patent for the best-selling arthritis drug Celebrex.

The court let stand a ruling by U.S. District Judge David G. Larimer in Rochester that found in March 2003 that the University of Rochester patent for so-called cox-2 inhibitors is invalid.

Larimer had declared the patent invalid because the university’s scientists did not produce a compound or pill. He described the university’s patent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.